brand logo

Am Fam Physician. 2004;69(8):1860

to the editor: I read with interest the article1 on bioterrorism agents in the May 1, 2003 issue of American Family Physician. This timely piece offered useful advice to assist family physicians on an important topic. I would like to recommend some information not included in the article.

First, the method of diagnosis that is described in Table 11 for plague should include culture of bubo aspirate (for bubonic plague) in addition to sputum, blood, and cerebrospinal fluid cultures for pneumonic and septicemic plague.

Second, Table 21 only describes the treatment for inhalational anthrax. There is a separate treatment regimen for cutaneous anthrax.2 Furthermore, clinicians can consider extending the usual 60-day anthrax prophylaxis to 100 days based on the possibility that disease may occur up to 100 days after exposure.3

IN REPLY: We appreciate Dr. Campos-Outcalt's pointing out the additional information on bioterrorism infections. He correctly notes that a culture of bubo aspirate should be done if a bubo is present. However, in a bioterrorism attack, persons will be more likely to have pulmonic plague rather than bubonic plague, and this is why we chose not to list this culture in Table 1 of our article.1 Cutaneous anthrax treatment is not listed in Table 2 of our article1 because any case of cutaneous anthrax seen during a bioterrorist attack is treated as presumed inhalation anthrax until proven otherwise.

Email letter submissions to afplet@aafp.org. Letters should be fewer than 400 words and limited to six references, one table or figure, and three authors. Letters submitted for publication in AFP must not be submitted to any other publication. Letters may be edited to meet style and space requirements.

This series is coordinated by Kenny Lin, MD, MPH, deputy editor.

Continue Reading


More in AFP

Copyright © 2004 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP.  See https://www.aafp.org/about/this-site/permissions.html for copyright questions and/or permission requests.